Citations 1
A randomized phase 3 trial of thalidomide and prednisone (TP) as maintenance therapy following autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM): An updated analysis of the NCIC Clinical Trials Group MY10 trial.
Trudel, Suzanne , White, Darrell , Sabry, Waleed , Belch, Andrew R. , Reiman, Tony , Shustik, Chaim, Kovacs, Michael J. , Sussman, Jonathan , Reece, Donna , Lacy, Martha Q. , Meyer, Ralph M., Shepherd, Lois E. , Whelan, Kate, Zhu, Liting , Chapman, Judy‐Anne W., Stewart, A. Keith, Hay, Annette E. , Bahlis, Nizar Jacques , Roy, Jean
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8591-8591
